Systemic sclerosis, morphoea and breast cancer
Open Access
- 9 August 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 45 (1) , 119-120
- https://doi.org/10.1093/rheumatology/kei072
Abstract
Sir, systemic sclerosis (SSc) and localized scleroderma (LS) are generally considered to be different entities. Raynaud's phenomenon, sclerodactyly, internal organ involvement and scleroderma-specific autoantibodies are usually not observed in LS. Nevertheless, there have been occasional reports of SSc and LS occurring together or LS evolving into SSc [1], suggesting a link between these disorders. We therefore describe a woman with SSc who developed typical lesions of generalized morphoea. A year later, invasive ductal carcinoma of breast was diagnosed. We discuss the rare coexistence of systemic sclerosis and morphoea, and the possible implications of breast cancer.Keywords
This publication has 7 references indexed in Scilit:
- Risk of cancer in patients with sclerodermaAnnals of the Rheumatic Diseases, 2003
- Trends in Incidence Rates of Invasive Lobular and Ductal Breast CarcinomaJAMA, 2003
- Rheumatic syndromes: Clues to occult neoplasiaSeminars in Arthritis and Rheumatism, 1999
- Localized scleroderma progressing to systemic disease. case report and review of the literatureArthritis & Rheumatism, 1993
- Coexistence of Morphea and Systemic SclerosisDermatology, 1993
- Capillary Abnormalities, Raynaud's Phenomenon, and Systemic Sclerosis in Patients With Localized SclerodermaArchives of Dermatology, 1992
- Anticentromere antibody in localized sclerodermaJournal of the American Academy of Dermatology, 1986